Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | 2C12H10I3N2O4.Mg |
| Molecular Weight | 1278.1694 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Mg++].CN(C(C)=O)C1=C(I)C(C([O-])=O)=C(I)C(NC(C)=O)=C1I.CN(C(C)=O)C2=C(I)C(C([O-])=O)=C(I)C(NC(C)=O)=C2I
InChI
InChIKey=QGZYHVVYXBFUSE-UHFFFAOYSA-L
InChI=1S/2C12H11I3N2O4.Mg/c2*1-4(18)16-10-7(13)6(12(20)21)8(14)11(9(10)15)17(3)5(2)19;/h2*1-3H3,(H,16,18)(H,20,21);/q;;+2/p-2
| Molecular Formula | Mg |
| Molecular Weight | 24.305 |
| Charge | 2 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C12H10I3N2O4 |
| Molecular Weight | 626.9322 |
| Charge | -1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Originator
Approval Year
Cmax
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
300 μg/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/3375780/ |
2310 mg single, intravenous dose: 2310 mg route of administration: Intravenous experiment type: SINGLE co-administered: |
METRIZOIC ACID serum | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE food status: UNKNOWN |
AUC
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
250 μg × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/3375780/ |
2310 mg single, intravenous dose: 2310 mg route of administration: Intravenous experiment type: SINGLE co-administered: |
METRIZOIC ACID serum | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE food status: UNKNOWN |
T1/2
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
75.1 min EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/3375780/ |
2310 mg single, intravenous dose: 2310 mg route of administration: Intravenous experiment type: SINGLE co-administered: |
METRIZOIC ACID serum | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE food status: UNKNOWN |
Funbound
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
100% EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/3375780/ |
2310 mg single, intravenous dose: 2310 mg route of administration: Intravenous experiment type: SINGLE co-administered: |
METRIZOIC ACID serum | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE food status: UNKNOWN |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Enrichment and analysis of secretory lysosomes from lymphocyte populations. | 2009-07-29 |
|
| Acute renal failure in rats. Interaction between contrast media and temporary renal arterial occlusion. | 1989-05-01 |
|
| Selective injection of iopentol, iohexol and metrizoate into the left coronary artery of the dog. Induction of ventricular fibrillation and decrease of aortic pressure. | 1987 |
|
| ECG changes and arrhythmias induced by ionic and non-ionic contrast media during coronary arteriography in dogs. | 1978-05-01 |
|
| Adverse general reactions to high doses of methylglucamine-based contrast media. | 1974-09 |
|
| Increased ventricular fibrillation during coronary arteriography with a new contrast medium preparation. | 1971-10 |
Sample Use Guides
In Vivo Use Guide
Sources: http://newdruginformation.com/Isopaque_280.htm
0.35 mg/ml; 140.1 mg/ml; 461.8 mg/ml
Route of Administration:
Intravascular
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:45:40 GMT 2025
by
admin
on
Mon Mar 31 17:45:40 GMT 2025
|
| Record UNII |
V717MS5D5B
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C390
Created by
admin on Mon Mar 31 17:45:40 GMT 2025 , Edited by admin on Mon Mar 31 17:45:40 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
20968-37-0
Created by
admin on Mon Mar 31 17:45:40 GMT 2025 , Edited by admin on Mon Mar 31 17:45:40 GMT 2025
|
PRIMARY | |||
|
CHEMBL1736
Created by
admin on Mon Mar 31 17:45:40 GMT 2025 , Edited by admin on Mon Mar 31 17:45:40 GMT 2025
|
PRIMARY | |||
|
V717MS5D5B
Created by
admin on Mon Mar 31 17:45:40 GMT 2025 , Edited by admin on Mon Mar 31 17:45:40 GMT 2025
|
PRIMARY | |||
|
DBSALT001366
Created by
admin on Mon Mar 31 17:45:40 GMT 2025 , Edited by admin on Mon Mar 31 17:45:40 GMT 2025
|
PRIMARY | |||
|
C76045
Created by
admin on Mon Mar 31 17:45:40 GMT 2025 , Edited by admin on Mon Mar 31 17:45:40 GMT 2025
|
PRIMARY | |||
|
100000086178
Created by
admin on Mon Mar 31 17:45:40 GMT 2025 , Edited by admin on Mon Mar 31 17:45:40 GMT 2025
|
PRIMARY | |||
|
244-130-8
Created by
admin on Mon Mar 31 17:45:40 GMT 2025 , Edited by admin on Mon Mar 31 17:45:40 GMT 2025
|
PRIMARY | |||
|
SUB03033MIG
Created by
admin on Mon Mar 31 17:45:40 GMT 2025 , Edited by admin on Mon Mar 31 17:45:40 GMT 2025
|
PRIMARY | |||
|
DTXSID901027371
Created by
admin on Mon Mar 31 17:45:40 GMT 2025 , Edited by admin on Mon Mar 31 17:45:40 GMT 2025
|
PRIMARY | |||
|
10080104
Created by
admin on Mon Mar 31 17:45:40 GMT 2025 , Edited by admin on Mon Mar 31 17:45:40 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |